FSCN1 and colorectal cancer: found that miR-451 was overexpressed in colorectal cancer cells, thereby inhibiting AMP-activated protein kinase (AMPK) from activating mammalian target of rapamycin (mTOR) complex 1 (mTORC1) that promotes FSCN1 expression.